Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a smartphone Check-In ease chronic jaw pain?

NCT ID NCT07764770

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 14, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether adding structured telemonitoring—weekly text messages and video calls—to standard conservative care helps people with temporomandibular disorder (TMD)-related jaw pain. Participants receive behavioral counseling, habit reversal training, and home exercises, with or without remote monitoring. Over 9 months, researchers measure changes in pain intensity, jaw movement, and oral behaviors to see if telemonitoring improves adherence and outcomes compared to usual in-office follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Structured telemonitoring (weekly text messaging and video consultations) added to standard conservative care
What this could lead to
If effective, this could offer a practical way to boost treatment adherence and reduce jaw pain without extra clinic visits.
What could go wrong
This is a small, early-stage trial, and the benefit of telemonitoring may be modest or not generalizable. It also depends on participants' ability to use mobile devices consistently.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jan 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-80 years. * Diagnosis of temporomandibular disorder (TMD) according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). * Presence of chronic orofacial pain persisting for more than 30 days. * Diagnosis of myofascial pain involving the masticatory muscles, with or without headache attributed to TMD. * Ability to use a mobile device compatible with telemonitoring procedures. Exclusion Criteria: * Systemic diseases affecting pain perception or neuromuscular function (including autoimmune, neurological, or neoplastic disorders). * History of severe orofacial trauma. * Previous major temporomandibular joint surgery. * Ongoing orthodontic treatment. * Current use of occlusal splints. * Current use of muscle relaxants or psychoactive medications.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myalgia of mastication muscle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Magna Graecia University of Catanzaro

    Catanzaro, CZ, 88100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.